Chile green-lights AstraZeneca COVID-19 vaccine trials

Chilean President Sebastián Piñera said the country’s health regulators had given the go-ahead for clinical trials of AstraZeneca’s COVID-19 vaccine. Piñera said the AstraZeneca trial would follow one by America’s Johnson & Johnson that is already underway and another by China’s Sinovac, whose first vaccine doses arrived in Chile on Wednesday. He also reported that Chile had signed a purchase agreement with Pfizer Inc and Germany’s BioNTech SE for 10 million doses of the vaccine they are jointly developing.

Chile sees Chaucer Energy’s ISG as potential solution to energy supply problems

Chaucer Energy announced a new technology called In Situ Gasification (ISG). Chile has embraced ISG as a potential solution to its energy supply problems. Chaucer is offering up to 27.5 million shares at $0.20, with a minimum subscription of $4.5 million and a maximum raise of $5.5 million. The company has identified three potential projects areas in southern Chile and has been granted exploration mining concessions near the town of Maullin as well as two other separate areas in the Magallan Basin: Rio Perez and Isla Riesco.